Home > Press > Iran Unveils New Nano Drug
Abstract:
Iran on Monday unveiled a new type of antibiotic named 'SinaDoxosome' used for treating various types of abdominal cancers with similar application to Doxorubicin.
The nano drug connects doxil to DNA and prevents the formation of nucleic acid. Studies show that doxil can rapidly diffuse into the cell and stick to chromatin around the nuclei. They also show that the medicine can stop cancerous cells very quickly.
The drug is 100 nanometer in diameter.
The tiny dimension of this drug makes possible its diffusion into the venous tissue of tumors, and it can carry a considerable amount of medicine.
Among the advantages of this drug over the similar non-nanometric drugs, mention can be made of higher solubility, lower toxicity, longer period of staying in the target cell, and more easily diffusion into the cell.
The aforementioned products will be presented in the Fourth Nanotechnology Festival and Exhibition (Iran Nano 2011).
####
For more information, please click here
Copyright © Fars News Agency
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||